Several major financial institutions have raised their price targets for Advanced Micro Devices (AMD) following the company's strong second-quarter performance and positive outlook driven by growth in AI, data center, and gaming segments. Benchmark Co. increased AMD's target to $210 from $170, citing strong Q2 results and a promising Q3 outlook despite a $700 million revenue loss in China during Q2. Barclays raised its target to $200 from $130, maintaining an Overweight rating and highlighting accelerating data center and client segments with MI-series products expected to generate over $10 billion in revenue. Raymond James, Piper Sandler, and Deutsche Bank also raised their targets to $200, $190, and $200 respectively, maintaining bullish ratings based on robust AI demand and market share gains. Other firms including JP Morgan, Stifel, TD Cowen, Evercore, and Wedbush raised their targets within a range of $188 to $205, reflecting confidence in AMD's product ramp and AI momentum. Separately, Bank of America raised Amphenol's target to $120 from $110, RBC increased Aptiv's target to $92 from $85, and UBS raised Birkenstock's target to $77 from $76. Additionally, Barclays raised Astera Labs' target to $155 from $75, HC Wainwright increased Alnylam Pharmaceuticals' target to $570 from $500, and Piper Sandler, Wells Fargo, and Morgan Stanley raised AppLovin's target to $500, $480, and $480 respectively.